Tirzepatide 40mg (R&D Only) by Alluvi Health Care is a cutting-edge compound designed exclusively for research and development purposes. This product stands out for its high potency and purity, making it ideal for advancing scientific studies in metabolic and endocrine disorders. With a focus on innovation, it supports pioneering research on dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonism, offering promising insights into diabetes and obesity treatment pathways. Its precise formulation ensures reliable results and consistent performance in laboratory settings, empowering researchers to explore new therapeutic potentials.